Fetal Macrosomia Clinical Trial
Official title:
Effect of Fetal Front-abdominal Wall Thickness on Birth Weight and Perinatal Outcome at 24-26. Gestational Weeks
Verified date | July 2017 |
Source | Kayseri Education and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Abnormal fetal development such as macrosomia can cause some complications on both fetus and mother.The measurement of fetal anterior abdominal wall thickness (FAWT) is an easy examination that it can be obtained during an examination of a pregnant woman by ultrasound. Macrosomia for fetus can lead to some morbidities. It can affect perinatal outcome and increase childbirth complications and operative birth. There are some studies scrutinizing the relationship between FAWT and diabetes in the literature. However there are few studies which scrutinize effect of FAWT on both abnormal fetal development and adverse perinatal outcomes in non-diabetic pregnancies and non high risk pregnancies. Hence the investigators wonder if FAWT can anticipate birth-weight or macrosomic infant or perinatal outcome regarding with macrosomia in the second trimester.
Status | Completed |
Enrollment | 96 |
Est. completion date | June 1, 2017 |
Est. primary completion date | April 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: A total of 96 women with low risk pregnancy coming to our clinic for a routine antenatal examination in 26-28th gestational weeks were included to this study and performed 75 gr- oral glucose tolerance test (OGTT). Exclusion Criteria: The participants with a positive 75-g OGTT were excluded. Additionally those following criteria were accepted as the exclusion criteria of this study: hypertension, preeclampsia, diabetes, fetal distress, fetal anomaly, multiple pregnancy, preterm labor, preterm premature rupture of membrane, placenta previa, polyhydramnios and intrauterine fetal growth restriction. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Kayseri Education and Research Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The relationship between fetal abdominal wall thickness and macrosomia | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00826904 -
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
|
||
Recruiting |
NCT06157684 -
Timing of Ambulation and Infant Birth Weight in Gestational Diabetes
|
N/A | |
Completed |
NCT02713568 -
Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)
|
N/A | |
Recruiting |
NCT03451838 -
Prediction of Fetal Macrosomia by US
|
||
Recruiting |
NCT02473991 -
Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
|
N/A | |
Unknown status |
NCT02371343 -
Fish Oil Supplementation in Women With Gestational Diabetes
|
N/A | |
Completed |
NCT02523222 -
Prophylactic Dextrose Gel for Newborns at High-risk for Hypoglycemia
|
N/A | |
Completed |
NCT03002246 -
Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
|
||
Recruiting |
NCT04399434 -
Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
|
||
Completed |
NCT00625781 -
Treatment of Impaired Glucose Tolerance in Pregnancy
|
N/A | |
Completed |
NCT00190320 -
DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia
|
Phase 4 | |
Not yet recruiting |
NCT06268392 -
A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
|
||
Recruiting |
NCT06067685 -
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
|